-
argenx announces collaboration with Broteio Pharma to develop therapeutic antibody for severe autoim
firstwordpharma
March 22, 2017
Breda, the Netherlands/Ghent, Belgium - argenx announced that it has entered into a new collaboration with Broteio Pharma B.V. to develop an antibody against a novel target...
-
MedImmune and Sanofi Pasteur form alliance to develop and commercialise potential next-generation re
worldpharmanews
March 08, 2017
MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, have announced an agreement to develop and commercialise MEDI8897 jointly.
-
Incyte and Agenus Amend Collaboration Agreement
firstwordpharma
February 15, 2017
Incyte Corporation and Agenus Inc. announced today that the companies have amended the License, Development and Commercialization Agreement that was originally entered into January 9, 2015.
-
Innova Biosciences introduces the Conjugate Check&Go! Kit for confirming successful conjugation
pharmaasia
February 06, 2017
This kit allows scientists to confirm, in one easy step, whether an antibody has been successfully conjugated before moving on to more extensive testing in their assay application.
-
Antinuclear antibody testing market worth USD 1,476.1 million USD by 2021
pharmaasia
January 22, 2017
The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this market.
-
Successful antibody trial in HIV-infected individuals
worldpharmanews
January 19, 2017
A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research (DZIF), has tested a new HIV neutralising antibody, called 10-1074, in humans.